Adjuvant Global Health Technology Fund DE, L.P. - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 16, 2024, Adjuvant Global Health Technology Fund DE, L.P.'s relationship to AN2 Therapeutics, Inc. (ANTX) is TenPercentOwner, and currently has 1,995,958 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Adjuvant Global Health Technology Fund DE, L.P. - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 17, 2024 | Sell -- (Common Stock) | 15907 | 19.65 | 377542 |
| Jan 17, 2024 | Sell -- (Common Stock) | 84093 | 19.65 | 1995958 |